Boustani J - Search Results

1

Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation.

Meunier S, Frontczak A, Balssa L, Blanc J, Benhmida S, Pernot M, Quivrin M, Martin E, Hammoud Y, Créhange G, Boustani J. Meunier S, et al. Among authors: boustani j. Cancers (Basel). 2023 Mar 21;15(6):1886. doi: 10.3390/cancers15061886. Cancers (Basel). 2023. PMID: 36980771 Free PMC article.

2

Evaluation of a 36 Gy elective node irradiation dose in anal cancer.

Lépinoy A, Lescut N, Puyraveau M, Caubet M, Boustani J, Lakkis Z, Fantoli M, Buffet-Miny J, Kim S, Bednarek C, Maingon P, Créhange G, Bosset JF. Lépinoy A, et al. Among authors: boustani j. Radiother Oncol. 2015 Aug;116(2):197-201. doi: 10.1016/j.radonc.2015.07.050. Epub 2015 Aug 12. Radiother Oncol. 2015. PMID: 26277433

3

Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.

Boustani J, Bertaut A, Galsky MD, Rosenberg JE, Bellmunt J, Powles T, Recine F, Harshman LC, Chowdhury S, Niegisch G, Yu EY, Pal SK, De Giorgi U, Crabb SJ, Caubet M, Balssa L, Milowsky MI, Ladoire S, Créhange G; Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators. Boustani J, et al. Acta Oncol. 2018 Apr;57(4):491-497. doi: 10.1080/0284186X.2017.1369565. Epub 2017 Aug 30. Acta Oncol. 2018. PMID: 28853615

4

Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.

Boustani J, Rivin Del Campo E, Blanc J, Peiffert D, Benezery K, Pereira R, Rio E, Le Prisé E, Créhange G, Huguet F. Boustani J, et al. Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):329-337. doi: 10.1016/j.ijrobp.2019.06.2542. Epub 2019 Jul 9. Int J Radiat Oncol Biol Phys. 2019. PMID: 31299242 Clinical Trial.

5

[No title available]

[No authors listed] [No authors listed] PMID: 33518228

6

Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Boustani J, Joseph ELM, Martin E, Benhmida S, Lecoester B, Tochet F, Mirjolet C, Chevalier C, Thibouw D, Vulquin N, Servagi S, Sun X, Adotévi O. Boustani J, et al. BMC Immunol. 2021 Jun 18;22(1):38. doi: 10.1186/s12865-021-00429-5. BMC Immunol. 2021. PMID: 34144673 Free PMC article.

7

Present and Future Research on Anal Squamous Cell Carcinoma.

Spehner L, Boustani J, Cabel L, Doyen J, Vienot A, Borg C, Kim S. Spehner L, et al. Among authors: boustani j. Cancers (Basel). 2021 Aug 2;13(15):3895. doi: 10.3390/cancers13153895. Cancers (Basel). 2021. PMID: 34359795 Free PMC article. Review.

8

Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies.

Boustani J, Lecoester B, Baude J, Latour C, Adotevi O, Mirjolet C, Truc G. Boustani J, et al. Cancers (Basel). 2021 Sep 29;13(19):4893. doi: 10.3390/cancers13194893. Cancers (Basel). 2021. PMID: 34638376 Free PMC article. Review.

9

[No title available]

[No authors listed] [No authors listed] PMID: 34700569

10

Long-Term Disease Control After locoregional Pelvic Chemoradiation in Patients with Advanced Anal Squamous Cell Carcinoma.

Grave A, Blanc J, De Bari B, Pernot M, Boulbair F, Noirclerc M, Vienot A, Kim S, Borg C, Boustani J. Grave A, et al. Among authors: boustani j. Front Oncol. 2022 Jul 22;12:918271. doi: 10.3389/fonc.2022.918271. eCollection 2022. Front Oncol. 2022. PMID: 35936677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page